Kasia J Lipska
Affiliation: Yale University
- WITHDRAWN: Promoting the use of DPP-4 inhibitors in AsiaKasia J Lipska
Fogarty International Clinical Research Fellow, Public Health Foundation of India PHFI, New Delhi, India Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA Electronic address
Diabetes Res Clin Pract . 2012..The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy...
- Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013Kasia J Lipska
Section of Endocrinology and Metabolism, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
Diabetes Care . 2016..To examine temporal trends in utilization of glucose-lowering medications, glycemic control, and rate of severe hypoglycemia among patients with type 2 diabetes (T2DM)...
- HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging StudyKasia J Lipska
Corresponding author Kasia J Lipska
Diabetes Care 36:3535-42. 2013..We examined the association between HbA1c level and self-reported severe hypoglycemia in patients with type 2 diabetes...
- Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one?Kasia J Lipska
Corresponding author Kasia J Lipska
Diabetes Care 36:3923-9. 2013..To determine which measures-impaired fasting glucose (IFG), elevated HbA1c, or both-best predict incident diabetes in older adults...
- Glucose variability and mortality in patients hospitalized with acute myocardial infarctionKasia J Lipska
Department of Internal Medicine, Yale University, New Haven, CT, USA
Circ Cardiovasc Qual Outcomes 5:550-7. 2012..Whether GV is associated with in-hospital mortality during AMI, after accounting for mean BG, is unknown...
- Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetesKasia J Lipska
Department of Medicine, Yale University School of Medicine, New Haven, CT 06520 8088, USA
Circ Cardiovasc Qual Outcomes 3:236-42. 2010..We examined the frequency of this practice and evaluated the associated outcomes of readmission and mortality...
- Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1cKasia J Lipska
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, P O Box 208088, 333 Cedar Street, SHM IE 61, New Haven, Connecticut 06520 8088, USA
J Clin Endocrinol Metab 95:5289-95. 2010..Hemoglobin A1c (A1c) was recently added to the diagnostic criteria for diabetes and prediabetes...
- National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011Kasia J Lipska
Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
JAMA Intern Med 174:1116-24. 2014..Trends in these hospitalizations and subsequent outcomes are not known...
- Management of blood glucose in patients with acute coronary syndromesKasia J Lipska
Yale University School of Medicine, New Haven, CT, USA
Rev Cardiovasc Med 13:e77-88. 2012..This article reviews data from observational studies and clinical trials and synthesizes this information into practical recommendations based on available evidence...
- Hypoglycemia and adverse outcomes: marker or mediator?Kasia J Lipska
Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, New Haven, CT, USA
Rev Cardiovasc Med 12:132-5. 2011..Nevertheless, continued efforts to avoid hypoglycemia are clearly warranted...
- Potential overtreatment of diabetes mellitus in older adults with tight glycemic controlKasia J Lipska
Section of Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut
JAMA Intern Med 175:356-62. 2015..In older adults with multiple serious comorbidities and functional limitations, the harms of intensive glycemic control likely exceed the benefits...
- Risk-standardized Acute Admission Rates Among Patients With Diabetes and Heart Failure as a Measure of Quality of Accountable Care Organizations: Rationale, Methods, and Early ResultsErica S Spatz
Section of Cardiovascular Medicine, Yale University School of Medicine Center for Outcomes Research and Evaluation, Yale New Haven Hospital Sections of Endocrinology General Internal Medicine Departments of Internal Medicine, Robert Wood Johnson Foundation Clinical Scholars Program Health Policy and Management Pediatrics, Yale University School of Medicine, New Haven, CT
Med Care 54:528-37. 2016....
- Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 DiabetesKasia J Lipska
Department of Internal Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut
JAMA 315:1034-45. 2016..There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes mellitus...
- Metformin in patients with type 2 diabetes and kidney disease: a systematic reviewSilvio E Inzucchi
Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut
JAMA 312:2668-75. 2014..However, the drug is contraindicated in many individuals with impaired kidney function because of concerns of lactic acidosis...